Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 8, 2013, Pages 934-942

  Hamed, Hossam O ^a,b   Ahmed, Salah R ^a   Alzolibani, Abdallatif ^a   Kamal, Manal M ^a,b   Mostafa, Marwa S ^a   Gamal, Rania M ^b   Atallah, Dalia A A ^b   Abd El Aall, Diaa Eldeen M ^b  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Anti phospholipid antibodies; cutaneous lupus erythematous; pregnancy; pregnancy complications; pregnancy outcome; systemic lupus erythematous

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ABORTION; ADULT; ADVERSE OUTCOME; ARTICLE; CESAREAN SECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; EGYPT; FEMALE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN INTENSIVE CARE; OBSTETRIC PATIENT; PARITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SAUDI ARABIA; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-PHOSPHOLIPID ANTIBODIES; CUTANEOUS LUPUS ERYTHEMATOUS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SYSTEMIC LUPUS ERYTHEMATOUS;

ABORTION, SPONTANEOUS; ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; CESAREAN SECTION; COHORT STUDIES; EGYPT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRIC LABOR, PREMATURE; PATIENT ADMISSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; SAUDI ARABIA; YOUNG ADULT;

EID: 84880317191     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12158     Document Type: Article

References (31)

1. Mecacci F, Bianchi B, Pieralli A, Mangani B, Moretti A, Cioni R, et al. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies. Rheumatology. 2009; 48 (3): 246-9.
2. Yuen SY, Krizova A, Ouimet JM, Pope JE,. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008; 2: 89-98.
3. Georgiou PE, Politi EN, Katsimmbri P, Sakka V, Drosos AA,. Outcome of lupus pregnancy: a controlled study. Rheumatology. 2000; 39 (9): 1014-9.
4. Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, et al. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmunity. 2012; 38 (2-3): 197-208.
5. Al Arfaj AS, Khalil N,. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010; 19 (14): 1665-73.
6. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S,. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986; 13 (4): 732-9.
7. Vinet E, Clarke AE, Gordon C, Urowitz MB, Hanly JG, Pineau CA, et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res. 2011; 63 (7): 1068-72.
8. Petri M,. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am. 1994; 20 (1): 87-118.
9. Loizou S, Byron MA, Englert HJ, David J, Hughes GR, Walport MJ,. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med. 1988; 68 (255): 525-31.
10. Furukawa F, Muto M,. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus. Arch Dermatol Res. 2009; 301 (1): 111-5.
11. Font J, Cervera R, Ramos-Casals M, García-Carrasco M, Sents J, Herrero C, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum. 2004; 33 (4): 217-30.
12. Wallace DJ,. New European recommendations (European League Against Rheumatism for the management of lupus erythematosus: American perspective. Pol Arch Med Wewn. 2008; 118 (7-8): 402-3.
13. Zecevic RD, Vojvodic D, Ristic B, Pavlovic MD, Stefanovic D, Karadaglic D,. Skin lesions-an indicator of disease activity in systemic lupus erythematosus? Lupus. 2001; 10 (5): 364-7.
14. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40 (9): 1725.
15. Levine JS, Branch DW, Rauch J,. The antiphospholipid syndrome. N Engl J Med. 2002; 346 (10): 752-63.
16. Mok MY, Leung PY, Lao TH, Lo Y, Chan TM, Wong WS, et al. Clinical predictors of fetal and maternal outcome in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis. 2004; 63 (12): 1705-6.
17. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS,. Lupus nephritis and pregnancy. Q J Med. 1992; 83 (300): 315-24.
18. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988; 319 (4): 189-94.
19. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brely RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4 (2): 295-306.
20. Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G, et al. Assessing disease activity in SLE patients during pregnancy. Lupus. 1999; 8 (8): 677-84.
21. Chauhan SP, Magann EF,. Screening for fetal growth restriction. Clin Obstet Gynecol. 2006; 49 (2): 284-94.
22. Le Huong D, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefèbvre G, Blétry O, et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol. 1997; 36 (7): 772-7.
23. Cortés-Hernández J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M,. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology. 2002; 41 (6): 643-50.
24. Le Thi Huong D, Wechsler B, Piette JC, Bletry O, Godeau P,. Pregnancy and its outcome in systemic lupus erythematosus. Q J Med. 1994; 87 (12): 721-9.
25. Rahman P, Gladman DD, Urowitz MB,. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol. 1998; 25 (8): 1526-30.
26. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996; 35 (2): 133-8.
27. Petri M, Allbritton J,. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol. 1993; 20 (4): 650-6.
28. Julkunen H, Kaaja R, Palosuo T, Gronhagen-Riska C, Teramo K,. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand. 1993; 72 (4): 258-63.
29. Aggarwal N, Sawhney H, Vasishta K, Chopra S, Bambery P,. Pregnancy in patients with systemic lupus erythematosus. Aust N Z J Obstet Gynaecol. 1999; 39 (1): 28-30.
30. Johnson MJ, Petri M, Witter FR, Repke JT,. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol. 1995; 86 (3): 396-9.
31. Kobayashi N, Yamada H, Kishida T, Kato EH, Ebina Y, Sakuragi N, et al. Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus. Am J Reprod Immunol. 1999; 42 (3): 153-9.